other material
confidence high
sentiment neutral
materiality 0.45
BioVie increases ATM offering capacity from $8.1M to $17.5M under sales agreement
BIOVIE INC.
- Filed prospectus supplement on Dec. 6, 2022 to raise maximum aggregate offering from $8.1M to $17.5M.
- Previously issued and sold 1,934,871 shares for net proceeds of approximately $7.4M (after ~$228K in fees).
- Shares sold via Controlled Equity Offering through agents Cantor Fitzgerald & Co. and B. Riley Securities.
- Up to $17.5M in additional shares of Class A common stock may now be sold under the at-the-market program.
- Prospectus supplement filed due to increase in public float since prior supplement dated Sept. 30, 2022.